Evaluation of Siemens Atellica AMH assay and comparison with Roche, Beckman and Ansh Labs
Overall, the Siemens Healthineers Atellica IM assay shows promise as an alternative method for AMH measurement, demonstrating good correlation with established assays. However, differences were observed between all assays, highlighting the importance of assay-specific interpretation for accurate clinical assessment.
Authors
- Charbel Abou‐Diwan
- Joe M El-Khoury (ORCID: https://orcid.org/0000-0002-9444-9540)
- Heidy Agustin (ORCID: https://orcid.org/0000-0002-0422-4322)
- Jason K. Y. Lee
- Matt Scheidegger
- Jieli Li
- Joanna Jones (ORCID: https://orcid.org/0000-0001-8033-987X)
- Emily Shang
Institutions
- The Ohio State University Wexner Medical Center (US)
- Yale University (US)
- Ohio State University Hospital (US)
- Siemens Healthcare (United States) (US)
Publication Details
- Journal
- Clinical Biochemistry
- Published
- 2024-12-13
- DOI
- https://doi.org/10.1016/j.clinbiochem.2024.110863
- Citations
- 2
- Primary Topic
- MRI in cancer diagnosis
- Type
- article
- Field-Weighted Citation Impact
- 0.81